Your selections:
Age-related mTOR in ovarian and endometrial cancers
Albendazole loaded albumin nanoparticles for ovarian cancer therapy
- Noorani, Lubna, Pourgholami, Mohammad Hossein, Liang, Mingtao, Morris, David Lawson, Stenzel, Martina
Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model
- Noorani, Lubna, Stenzel, Martina, Liang, Roger, Pourgholami, Mohammad H., Morris, David L.
Biomarkers for epithelial ovarian cancers
- Jakubowska, Anna, Gronwald, Jacek, Eils, Roland, Lubińki, Jan, Scott, Rodney J., Hamann, Ute, Menkiszak, Janusz, Górski, Bohdan, Huzarski, Tomasz, Byrski, Tomasz, Toloczko-Grabarek, Aleksandra, Gilbert, Michael, Edler, Lutz, Zapatka, Marc
Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
- Moran-Jones, Kim, Gloss, Brian S., Spong, Suzanne M., Scarlett, Christopher J., Hacker, Neville F., Ghosh, Sue, Mok, Samuel C., Birrer, Michael J., Samimi, Goli, Murali, Rajmohan, Chang, David K., Colvin, Emily K., Jones, Marc D., Yuen, Samuel, Howell, Viive M., Brown, Laura M., Wong, Carol W.
Early serous ovarian carcinogenesis: understanding the genetic and lifestyle factors
- Bangaraswamaiah Nagendra, Prathima
First recurrent large genomic rearrangement in the BRCA1 gene found in Poland
- Rudnicka, Helena, Masojc, Bartlomiej, van de Wetering, Thierry, Debniak, Tadeusz, Cybulski, Cezary, Gronwald, Jacek, Lubinski, Jan, Gorski, Bohdan, Scott, Rodney
Genesis of ovarian cancer: understanding the mechanisms of oviductal epithelial cell homoeostasis
- Bowden, N. A., Smyth, M., Jaaback, K., Ashton, K. A., Scurry, J.
In Vivo cell fate tracing provides no evidence for mesenchymal to epithelial transition in adult fallopian tube and uterus
- Ghosh, Arnab, Syed, Shafiq M., Kumar, Manish, Carpenter, Tyler J., Teixeira, Jose M., Houairia, Nathaniel, Negi, Sumedha, Tanwar, Pradeep S.
In vivo genetic cell lineage tracing reveals that oviductal secretory cells self-renew and give rise to ciliated cells
- Ghosh, Arnab, Syed, Shafiq M., Tanwar, Pradeep S.
Investigating the role of microenvironment and matrix stiffness in ovarian cancer development
- Tanwar, Pradeep S., Mohapatra, Gayatry, Chiang, Sarah, Engler, David A., Zhang, LiHua, Kaneko-Tarui, Tomoko, Ohguchi, Yasuyo, Birrer, Michael J., Teixeira, Jose M.
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients
- Jacob, Francis, Ukegjini, Kristjan, Fink, Daniel A., Hacker, Neville F., Heinzelmann-Schwarz, Viola A., Nixdorf, Sheri, Ford, Caroline E., Olivier, Jake, Caduff, Rosmarie, Scurry, James P., Guertler, Rea, Hornung, Daniela, Mueller, Renato
Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families
- Dębniak, Tadeusz, Gromowski, Tomasz, Cybulski, Cezary, Serrano-Fernandez, Pablo, Lubiński, Jan, Scott, Rodney J., Gronwald, Jacek, Huzarski, Tomasz, Byrski, Tomasz, Kurzawski, Grzegorz, Dymerska, Dagmara, Górski, Bohdan, Paszkowska-Szczur, Katarzyna
- Scurry, James, van Zyl, Belinda, Gulliver, Damien, Otton, Geoffrey, Jaaback, Kenneth, Lombard, Janine, Vilain, Ricardo E., Bowden, Nicola A.
Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
Oncolysis of human ovarian cancers by echovirus type 1
- Shafren, Darren R., Sylvester, Dianne, Johansson, E. Susanne, Campbell, Ian G., Barry, Richard D.
Oncolysis of human ovarian cancers by echovirus type 1
- Shafren, Darren Raymond, Sylvester, Dianne, Johansson, Eva Susan, Campbell, I. G., Barry, Richard Desmond
Are you sure you would like to clear your session, including search history and login status?